Latest Mergers And Acquisitions News

Page 2 of 183
The Supreme Court of New South Wales has approved I Squared Capital’s proposed acquisition of oOh!media, moving the $1.68-per-share takeover to its final legal steps. The scheme is expected to become effective after the court orders are lodged with ASIC on 19 November, with implementation targeted for 10 December.
Elise Vega
Elise Vega
18 Nov 2026
Genetic Signatures has abandoned its proposed merger with Microba Life Sciences after Microba said it lacked the financial capacity to complete the transaction without fresh capital. GSS also declined to provide unsecured working capital funding, leaving the shareholder vote and Takeovers Panel process to be unwound separately.
Ada Torres
Ada Torres
18 Nov 2026
Genetic Signatures has ended its proposed merger with Microba Life Sciences after Microba said it could not complete the transaction without raising more capital. The decision also removes the deal’s shareholder vote and leaves a Takeovers Panel application awaiting clarification.
Ada Torres
Ada Torres
18 Nov 2026
AES has received final approval from the Federal Energy Regulatory Commission for its acquisition by a consortium led by Global Infrastructure Partners and EQT. The US$15-per-share cash deal is expected to close on or about December 2, subject to remaining conditions.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Gorilla Gold Mines has secured firm commitments for a A$60 million placement, clearing the minimum funding hurdle for its proposed Cosmos acquisition while giving the company cash to pursue a large Western Australian drilling program. The deal brings resources investor Tembo Capital onto the register, but shareholder approval and other conditions still stand between Gorilla and completion.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Nuix has given Haveli five weeks of exclusive access to pursue a potential A$2.75-per-share cash takeover, valuing certainty at a substantial premium to the market price. The proposal is still non-binding, but the board intends to recommend it if Haveli delivers a binding offer on at least those terms.
Sophie Babbage
Sophie Babbage
18 Nov 2026
Viatris has completed its US$1.69 billion cash acquisition of Pacira BioSciences, taking full ownership of the non-opioid pain management company. Pacira is expected to contribute US$90 million to US$100 million in revenue over the remainder of 2026.
Victor Sage
Victor Sage
18 Nov 2026
Global Lithium’s proposed Titan Australia Mining takeover has cleared a procedural court hurdle, with shareholders now set to vote on the scheme in December. The transaction remains subject to shareholder approval and further conditions, with the Scheme Booklet and independent expert’s report still to be released.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Vault Minerals’ merger with Genesis Minerals has cleared its final legal hurdle and is now legally effective, setting the transaction on course for implementation next week. Vault shares are expected to stop trading after 17 November, while the final consideration mix and any scaleback remain unresolved.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Microba Life Sciences has been suspended from trading after revised terms for its proposed Genetic Signatures merger left it unable to complete the second tranche of its institutional placement. The company says it is assessing alternative funding while its cashflow runway narrows.
Victor Sage
Victor Sage
17 Nov 2026
Mayne Pharma has agreed to a A$6.40-a-share cash takeover by Hungary’s Gedeon Richter, valuing the company’s equity at approximately A$604 million. The recommended scheme still depends on regulatory clearances, shareholder and court approval, and completion of Mayne’s international business sale.
Victor Sage
Victor Sage
17 Nov 2026
Aon has completed its US$17.0 billion acquisition of USI, creating a substantially larger US middle-market insurance platform while drawing US$4.0 billion in new term loans. The deal also installs USI chief executive Michael Sicard as Aon’s president and middle-market leader, with US$395 million in expected net adjusted EBITDA synergies now to be delivered.
Victor Sage
Victor Sage
17 Nov 2026

Browse the archive

Full archive